Overview

MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-0941 in Japanese patients with Type 2 Diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.